K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
J.M. Ostrem(Broad Institute), Kevan M. Shokat(Howard Hughes Medical Institute), Martin L. Sos(German Cancer Research Center), James A. Wells(University of California, San Francisco), Ulf Peters(Howard Hughes Medical Institute)
Cited by 2,511
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k